📄 Extracted Text (272 words)
From:
Sent: Thursday, October 26, 2017 11:53 PM
To: Jeffrey E.
Subject: Re:
Tomorrow
Please note, my email address has changed to
On Oct 26, 2017, at 7:48 PM, jeffrey E. <[email protected] <mailto:[email protected]» wrote:
when should i start the z pak. ?
On Thu, Oct 26, 2017 at 7:43 PM > wrote:
Z pak
Please note, my email address has changed to
On Oct 26, 2017, at 7:41 PM, [email protected] <mailto:[email protected]>"
<[email protected] <mailto:[email protected]» wrote:
bad sore throat. nose just begiinning. . thoughts. keflex . z pak. ceftin?
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_01374427
EFTA02371620
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected] <[email protected]> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
2
EFTA_R1_01374428
EFTA02371621
ℹ️ Document Details
SHA-256
18fcba9e1d36d29cb05179e79dff43955291c6daab5b1baf7cedf03d6baccf84
Bates Number
EFTA02371620
Dataset
DataSet-11
Document Type
document
Pages
2
Comments 0